886762-75-0

Basic information

• Product Name: 4-BROMO-3-FLUORO-2-NITROANILINE
• Synonyms: 4-BROMO-3-FLUORO-2-NITROANILINE;6-Amino-3-bromo-2-fluoronitrobenzene;4-Bromo-3-fluoro-2-nitroaniline 97%;4-BroMo-3-fluoro-2-nitro-phenylaMine;4-Bromo-3-fluoro-2-nitroaniline97%
• CAS NO: 886762-75-0
• Molecular Formula: C₆H₄BrFN₂O₂
• Molecular Weight: 235.01
• Mol File: 886762-75-0.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 322.7 °C at 760 mmHg
• Flash Point: 149 °C
• Appearance: /
• Density: 1.896 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: -2.06±0.10(Predicted)
• CAS DataBase Reference: 4-BROMO-3-FLUORO-2-NITROANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-FLUORO-2-NITROANILINE(886762-75-0)
• EPA Substance Registry System: 4-BROMO-3-FLUORO-2-NITROANILINE(886762-75-0)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 886762-75-0(Hazardous Substances Data)

Usage

General Description

4-Bromo-3-fluoro-2-nitroaniline is a chemical compound with the molecular formula C6H4BrFNO2. It is a derivative of aniline, containing a bromine atom, a fluorine atom, and a nitro group attached to the aromatic ring. 4-Bromo-3-fluoro-2-nitroaniline is commonly used in the synthesis of pharmaceuticals, agrochemicals, and dyes. It is also known for its use in organic synthesis and as an intermediate in the production of other chemicals. Due to its potential for toxicity, it is important to handle 4-Bromo-3-fluoro-2-nitroaniline with caution and use appropriate safety precautions when working with this compound.

Upstream product

• 19064-24-5 2,6-difluoro-1-nitrobenzene 

Relevant articles and documents

LIPOXYGENASE INHIBITORS

Various embodiments of the present disclosure are directed to compounds having Formula (I), Formula (IA), Formula (IB), Formula (IC), Formula (ID), Formula (IE), and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases, and/or treating associated diseases, such as Alzheimer's disease. In some embodiments, the compounds may be administered to a patient as part of a pharmaceutical formulation.

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (I) USEFUL AS EP3 RECEPTOR ANTAGONISTS

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula I, II or any of Compounds 100-128 or any of those in Tables 2 or 3) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.